IP Verse

Sanovel Iiac San Ve Tic competitive analysis

Latest oppositions filed by Sanovel Iiac San Ve Tic

Explore patent oppositions filed by Sanovel Iiac San Ve Tic against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026

Patent Number	Title	Applicant	Opposition Date
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Dec 7, 2023
EP2981255	Therapeutic Uses Of Empagliflozin	BOEHRINGER INGELHEIM	Jun 13, 2023
EP2515871	Solid Pharmaceutical Dosage Form	RATIOPHARM	Jun 14, 2016
EP2075000	Combination Of Azelastine And Ciclesonide	CIPLA	Apr 11, 2016
EP1944322	Treatment Of Tnf Alpha Related Disorders	ABBOTT BIOTECHNOLOGY	Dec 9, 2015
EP1819326	Dosage Regimen Of An S1P Receptor Agonist	NOVARTIS	Mar 31, 2015

Latest PTAB cases involving Sanovel Iiac San Ve Tic

Discover the latest PTAB cases involving Sanovel Iiac San Ve Tic, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sanovel Iiac San Ve Tic with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
SANOVEL IIAC SAN VE TIC	6	-	-	-
ABBVIE BIOTECHNOLOGY	-	41	-	22
BOEHRINGER INGELHEIM	45	232	8	9
NOVARTIS	12	564	-	21